Published in

Nature Research, Nature Communications, 1(9), 2018

DOI: 10.1038/s41467-018-05427-7

Links

Tools

Export citation

Search in Google Scholar

Identification of nine new susceptibility loci for endometrial cancer

Journal article published in 2018 by Tracy A. O’Mara ORCID, Dylan M. Glubb ORCID, Frederic Amant, Daniela Annibali ORCID, Katie Ashton, John Attia ORCID, Paul L. Auer, Matthias W. Beckmann, Amanda Black, Manjeet K. Bolla, Hiltrud Brauch ORCID, Hermann Brenner, Louise Brinton, Daniel D. Buchanan ORCID, Barbara Burwinkel and other authors.
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Red circle
Postprint: archiving forbidden
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO

Abstract

AbstractEndometrial cancer is the most commonly diagnosed cancer of the female reproductive tract in developed countries. Through genome-wide association studies (GWAS), we have previously identified eight risk loci for endometrial cancer. Here, we present an expanded meta-analysis of 12,906 endometrial cancer cases and 108,979 controls (including new genotype data for 5624 cases) and identify nine novel genome-wide significant loci, including a locus on 12q24.12 previously identified by meta-GWAS of endometrial and colorectal cancer. At five loci, expression quantitative trait locus (eQTL) analyses identify candidate causal genes; risk alleles at two of these loci associate with decreased expression of genes, which encode negative regulators of oncogenic signal transduction proteins (SH2B3 (12q24.12) and NF1 (17q11.2)). In summary, this study has doubled the number of known endometrial cancer risk loci and revealed candidate causal genes for future study.